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Aims: To determine if computed tomographic pulmonary angiography (CTPA) was overemployed in the
evaluation of hospitalized patients with suspected acute pulmonary embolism (PE).
Methods: Data were gathered retrospectively on hospitalized patients (n 185) who had CTPA for suspected
PE between June and August 2009 at our institution.
Results: CTPA was done in 185 hospitalized patients to diagnose acute PE based on clinical suspicion. Of
these, 30 (16.2%) patients were tested positive for acute PE on CTPA. The Well’s pretest probability for PE
was low, moderate, and high in 77 (41.6%), 83 (44.9%), and 25 (13.5%) patients, respectively. Out of the 30
PE-positive patients, pretest probability was low in 2 (6.6%), moderate in 20 (66.7%), and high in 8 (26.6%)
(p 0.003). Modified Well’s criteria applied to all patients in our study revealed 113 (61%) with low and 72
(39%) with high clinical pretest probability. When modified Well’s criteria was applied to 30 PE-positive
patients, 10 (33.3%) and 20 (66.6%) were found to have low and high pretest probability, respectively (p 
0.006). D-dimer assay was done in 30 (16.2%) of the inpatients with suspected PE and all of them were found
to have elevated levels. A lower extremity duplex ultrasound confirmed deep venous thrombosis in 17 (9.1%)
of the patients with suspected PE, at least 1 week prior to having CTPA.
Conclusion: Understanding the recommended guidelines, evidence-based literature, and current concepts in
evaluation of patients with suspected acute PE will reduce unnecessary CTPA examinations.
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C
omputed tomographic pulmonary angiography
(CTPA) has emerged as a prominent imaging
technique to investigate patients for suspected
pulmonary embolism (PE; 1, 2). In 1980, 3 million CT
scans were done in the United States, which increased
to 70 million in 2007 (3, 4). Burge et al. looked at a
New York State Statewide Planning and Research
Cooperative System database with 24,871,131 patients
and found that the number of PE diagnoses nearly
doubled, from 2,590 in 1994 to 4,920 in 2004 but PE
deaths did not vary significantly over time, from 157 in
1994 to 159 in 2004. This suggests that the increased use
of CTPA with increased diagnosis of PE did not have a
corresponding decline in mortality (5). CTPA can also
provide a greater detail of other pathology in the chest
causing the patient’s symptoms, but it is not without its
adverse effects due to radiation and contrast exposure.
This study investigates if CTPA is being overemplo-
yed without appropriately understanding the current
concepts in the evaluation of suspected PE.
Materials and methods
A retrospective study was done examining a 3-month
period (June August) in 2009 at a 475-bedded hospital,
with the institutional review board approval. Electronic
medical records of all hospitalized patients who under-
went a CTPA for suspected PE during this period were
reviewed. Data on demographics, clinical presentation,
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simultaneous usage of other investigations, including
D-dimer and lower extremity ultrasonography (USG),
were collected and analyzed. The Well’s criteria (Table 2)
and modified Well’s criteria (Table 3) were used (2).
Results
CTPA was done in 185 hospitalized patients to diagnose
acute PE based on clinical suspicion. Of these, 30 (16.2%)
patients were tested positive for acute PE on CTPA. The
Well’s pretest probability for PE was low, moderate, and
high in 77 (41.6%), 83 (44.9%), and 25 (13.5%) patients,
respectively. Out of the 30 PE-positive patients, pretest
probability was low in 2 (6.6%), moderate in 20 (66.7%),
and high in 8 (26.6%). Modified Well’s criteria applied to
all patients in our study revealed 113 (61%) with low and
72 (39%) with high clinical pretest probability. When
modified Well’s criteria were applied to PE-positive
patients, 10 (33.3%) and 20 (66.6%) were found to have
low and high pretest probability, respectively.
A chi-square test of general association was conducted
to determine if there is a significant relationship between
the frequency of PE status and Well’s scoring categories
for the entire sample (N 185). Results revealed a
statistically significant association (p 0.003). A statis-
tical analysis done on modified Well’s pretest probability
alone for acute PE revealed a sensitivity, specificity,
positive predictive value and negative predictive value
of 66.6, 66.4, 27.7 and 91.1%, respectively in our study
population. D-dimer assay was done in 30 (16.2%)
inpatients with suspected PE and all of them were found
to have elevated levels. A lower extremity USG confirmed
deep venous thrombosis (DVT) in 17 (9.1%) patients
with suspected PE, at least 1 week prior to having CTPA.
ventilation perfusion (VQ) scan was done in 36 hospita-
lized patients compared to 185 CTPA studies during this
time period at our institution.
Discussion
CTPA positivity quoted in literature ranges from 13 to
33% in suspected PE patients (6, 7). In our institution, we
had 16% of patients tested positive for acute PE on
CTPA, which is at the lower end of the prevalence range,
suggesting that we are overemploying CTPA in this
patient population. Poor patient selection secondary to
non-adherence to the recommended guidelines for eva-
luation of PE, along with the easy availability of CTPA
imaging most likely contributed to these results. CT is
readily available round the clock, whereas our nuclear
medicine department provides access for a VQ scan
during working hours on weekdays. Also, physicians
may be worried about the medico-legal implications of an
undiagnosed PE, thus practicing defensive medicine.
The incidence of contrast-induced nephropathy after
having CTPA in patients for suspected PE is up to 12%
(8, 9). Brenner et al. estimated that 1.5 2.0% of incident
cancers could be attributed to radiation exposure from
CT scans in the United States (10). The radiation risk is
considerably higher particularly in younger patients,
women and all patients who have repeated examinations
(11). Although manufacturers and radiologists are mak-
ing every effort to reduce the CT radiation dose without
affecting the clinical usefulness of the study, reduction in
radiation risk could be achieved primarily by decreasing
the number of unnecessary imaging with appropriate
justification (12, 13). The radiation dose information
can be collected and tracked and this information was
provided to patients, clinicians, and radiologists before
performing the imaging to understand ones risk of future
complications. In patients with low pretest probability,
it may be appropriate for the physicians to explain the
patient’s condition along with pros and cons of imaging.
This informed decision making may help the patient
choose to wait and watch before proceeding with CTPA,
which in turn may minimize medico-legal complications
and reduce some inappropriate imaging.
Usage of VQ scans in suspected PE with normal chest
radiograph results in considerably lower radiation ex-
posure with comparable negative predictive value to
CTPA (14). The total effective radiation from CTPA is
up to five times greater than that from VQ scan and the
cost of CTPA is nearly twice that of a VQ scan (14).
Anderson’s study on 1,417 patients with high pretest
Table 1. Well’s criteria
Clinical symptoms of DVT (leg swelling, pain with palpation) 3.0
Other diagnosis less likely that PE 3.0
Heart rate 100 1.5
Immobilization (]3 days) or surgery in previous 4 weeks 1.5
Previous DVT/PE 1.5
Hemoptysis 1.0
Malignancy 1.0
Table 2. Well’s clinical pretest probability
Probability Score
Low 52
Moderate 2 6
High ]6
Table 3. Modiﬁed Well’s clinical pretest probability
Probability Score
PE unlikely 54
PE likely  4
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mortality difference between CTPA and VQ scan groups,
suggesting that VQ scan is a safer and viable alternative
when studying patients for PE (1).
In patients with acute PE, lower extremity duplex USG
is positive in 50% of patients with clinical signs and
symptoms of DVT (16, 17). In patients with co-existing
clinical DVT, duplex USG as an initial imaging test is
often sufficient to confirm venous thromboembolism
(VTE), precluding the need for further testing (18, 19).
We believe 9.1% of patients with positive clinical DVTon
lower extremity USG in our study could have avoided
CTPA.
D-dimer assay is a very sensitive but non-specific
screening test for VTE as it is elevated in many conditions
(20). A study done by Rathbun et al. revealed that a
normal D-dimer assay was found only in 10% of the
hospitalized patients with clinically suspected PE and
negative CTPA or VQ scan, suggesting its limited clinical
utility in this group (21). It has been shown that a normal
D-dimer assay in patients with low (18, 22) or inter-
mediate (23) pretest probability safely eliminates the need
for further diagnostic testing. The Well’s criteria, pretest
probability categorization, and utility of D-dimer were
established based on the study that was done on patients
presenting to emergency department (22). Christopher
Study Investigators recommended the use of D-dimer
assay and modified clinical pretest probability after
analyzing 3,306 patients of which 82% were outpatients
(2), but we studied hospitalized patients. Therefore, it is
difficult to triage hospitalized patients with suspected PE
for further imaging in low pretest probability groups in
view of such a low specificity of D-dimer assay in this
group. In Well’s criteria, ‘alternative diagnosis less likely
than PE’ has a high interobserver variability, placing the
same patient in a different category depending on who
calculates it (24).
We acknowledge the limitations of a retrospective
study where data might not be completely obtainable
but care was taken to gather all of the information at the
time of study. To evaluate current practice at our
institution, the study was designed to be in retrospective
nature, in order to eliminate the Hawthorne effect. We
used Well’s and modified Well’s scoring system in our
study but not the revised Geneva scoring system, which
only uses objective measures. This may have reduced the
interobserver variability in assessing the pretest prob-
ability but evidence is lacking to prove that one scoring
system is better than the other in hospitalized patients.
Conclusion
We recommend the importance of adherence to clinical
guidelines to avoid unnecessary CTPA and potential
complications associated with radiation and contrast
administration.
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